Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma
2015; Ferrata Storti Foundation; Volume: 101; Issue: 3 Linguagem: Inglês
10.3324/haematol.2015.136929
ISSN1592-8721
AutoresNiels Weinhold, David H. Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlinde Egerer, Hans Salwender, I. Blau, Katja Weisel, Jens Hillengaß, Marc S. Raab, Dirk Hose, Hartmut Goldschmidt, A. Jauch,
Tópico(s)Glycosylation and Glycoproteins Research
ResumoThe impact of MYC locus aberrations on the outcome of multiple myeloma (MM) patients is still a matter of debate. The aim of this study was to further investigate their influence on the survival of MM patients treated with high-dose chemotherapy. Our data suggest that the favorable prognosis factor
Referência(s)